Public opinion on a mandatory COVID-19 vaccination policy in France: a cross-sectional survey.


Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 29 09 2021
revised: 26 10 2021
accepted: 27 10 2021
pubmed: 15 11 2021
medline: 16 3 2022
entrez: 14 11 2021
Statut: ppublish

Résumé

Reaching the last pockets of unvaccinated people is challenging, and has led to the consideration of mandatory vaccination for coronavirus disease 2019 (COVID-19). Our aim was to assess attitudes toward mandatory COVID-19 vaccination in France before the announcement of-and factors associated with opposition to-this type of policy. Between the 10th and 23rd May 2021, we conducted a cross-sectional online survey among a representative sample of the French population aged 18 and over, and a specific sample of the French senior population aged over 65. Among 3056 respondents, 1314 (43.0%) were in favour of mandatory COVID-19 vaccination, 1281 (41.9%) were opposed to such a policy, and 461 (15.1%) were undecided. Among opponents to mandatory COVID-19 vaccination for the general population, 385 (30.05%) were in favour of mandatory COVID-19 vaccination for healthcare workers (HCWs). In multivariate analysis, the age groups 18-24 and 25-34 years were significantly more opposed than the reference group (>75 years old) with respective adjusted odds ratio (aOR) and 95% confidence interval (95%CI) 4.67 (1.73-12.61) and 3.74 (1.57-8.93). Having no intention of getting COVID-19 vaccination was strongly associated with opposition to mandatory vaccination (aOR 10.67, 95%CI 6.41-17.76). In comparison with partisans of the centre, partisans of the far left and green parties were more likely to be opposed to mandatory COVID-19 vaccine, with respective aORs (95%CI) of 1.89 (1.06-3.38) and 2.08 (1.14-3.81). Attitudes toward mandatory COVID-19 vaccination are split in the French general population, and the debate might become politicized.

Identifiants

pubmed: 34774756
pii: S1198-743X(21)00617-0
doi: 10.1016/j.cmi.2021.10.016
pmc: PMC8912915
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

433-439

Informations de copyright

Copyright © 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Références

N Engl J Med. 2020 May 21;382(21):1969-1973
pubmed: 32227757
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Appl Psychol Health Well Being. 2021 Nov;13(4):986-995
pubmed: 34032388
Soc Sci Med. 2020 Nov;265:113414
pubmed: 33038683
Milbank Q. 2019 Sep 16;:
pubmed: 31529546
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
J Eval Clin Pract. 2021 Aug;27(4):996-1003
pubmed: 34060686
JAMA Netw Open. 2020 Dec 1;3(12):e2033324
pubmed: 33337490
Nature. 2019 Jul;571(7766):469-472
pubmed: 31332351
EClinicalMedicine. 2021 Oct;40:101109
pubmed: 34522870
Vaccine. 2020 Oct 21;38(45):7002-7006
pubmed: 32988688
J Health Polit Policy Law. 2019 Dec 1;44(6):823-854
pubmed: 31408878
PLoS One. 2021 May 10;16(5):e0248372
pubmed: 33970933

Auteurs

Amandine Gagneux-Brunon (A)

Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Jean Monnet, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530, France; CIC INSERM 1408 Vaccinologie, CHU de Saint-Etienne, France; Chaire PREVACCI, Université Jean Monnet, Saint-Etienne, France; Inserm, F-CRIN, I-REIVAC/COVIREIVAC, 75679 Paris, France. Electronic address: amandine.gagneux-brunon@chu-st-etienne.fr.

Elisabeth Botelho-Nevers (E)

Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Jean Monnet, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530, France; CIC INSERM 1408 Vaccinologie, CHU de Saint-Etienne, France; Chaire PREVACCI, Université Jean Monnet, Saint-Etienne, France.

Marion Bonneton (M)

Inserm, F-CRIN, I-REIVAC/COVIREIVAC, 75679 Paris, France.

Patrick Peretti-Watel (P)

Observatoire Régional de La Santé Paca, Marseille, France; VITROME (Aix Marseille Université, IRD, AP-HM, SSA), Marseille, France.

Pierre Verger (P)

Observatoire Régional de La Santé Paca, Marseille, France; VITROME (Aix Marseille Université, IRD, AP-HM, SSA), Marseille, France.

Odile Launay (O)

Inserm, F-CRIN, I-REIVAC/COVIREIVAC, 75679 Paris, France; Université de Paris, Inserm CIC 1417, Assistance Publique - Hôpitaux de Paris, Hôpital Cochin, 75679 Paris, France.

Jeremy K Ward (JK)

VITROME (Aix Marseille Université, IRD, AP-HM, SSA), Marseille, France; CERMES3 (INSERM, CNRS, EHESS, Université de Paris), Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH